Dr Sydney Hiller, Ph.D.

Sydney Hiller, Ph.D., specializes in navigating evolving regulatory and scientific challenges in the pharmaceutical, medical device, and consumer products industries across dynamic, global environments. Sydney has a proven track record of success integrating scientific rigor with regulatory strategy to support innovative product development, regulatory submission and market entry, and ongoing compliance in challenging sectors including tobacco harm reduction and cannabis. Her ability to distill intricate scientific concepts into actionable plans has consistently driven success in these high-stakes, regulated environments. Sydney received her Ph.D. in Chemistry from the University of Southern California and her B.A. from New York University. During her studies, she worked under Raphael Mechoulam, commonly known as the father of cannabis research. In addition to her active participation in numerous professional societies, Sydney is passionate about advancing women in STEM fields. She has served as a mentor for both Women in Science & Engineering (WiSE) and Women in Chemistry (WiC) and is a member of Organization of Women in Nicotine and Tobacco (OWNiT).